GO:1903392 negative regulation of adherens junction organization: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903392 describes any process that stops, prevents, or reduces the frequency, rate, or extent of adherens junction organization [QuickGO].
• Adherens junctions are cadherin-based cell-cell adhesion complexes whose disassembly is required for epithelial-to-mesenchymal transitions, tissue remodeling, and endothelial barrier regulation [1, 4].
• Negative regulation of adherens junction organization is driven by Rho GTPase signaling, growth factor pathways, and cytoskeletal forces that promote junction disassembly [1, 2, 4, 5].
• Key proteins include RhoA, Rac1, Cdc42, E-cadherin, β-catenin, ZO-1, and merlin/NF2, which coordinate junction stability and remodeling [1, 2, 6, 7].
• Dysregulated adherens junction disassembly contributes to cancer progression, vascular leak, and developmental defects [3, 4, 7].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of genes that negatively regulate adherens junction organization.
Description
Adherens junctions are essential cell-cell adhesion structures that maintain tissue architecture and barrier function. The Gene Ontology term GO:1903392, negative regulation of adherens junction organization, refers to any process that stops, prevents, or reduces the frequency, rate, or extent of adherens junction organization [QuickGO]. This regulatory process is critical because controlled disassembly of adherens junctions is required for normal developmental processes such as epithelial-to-mesenchymal transition, wound healing, and endothelial remodeling [1, 4]. Conversely, excessive or inappropriate negative regulation contributes to pathological conditions including cancer metastasis and vascular permeability [3, 7]. Research into GO:1903392 has revealed that multiple signaling pathways converge to destabilize adherens junctions. Rho GTPases, including RhoA, Rac1, and Cdc42, are central regulators of junction dynamics, with RhoA activation often promoting junction disassembly. Growth factor signaling through Ras and glucocorticoid-regulated pathways can also down-regulate junctional components [2, 4]. Mechanical forces, such as shear stress in endothelial cells, drive adherens junction remodeling through cytoskeletal tension. Understanding these mechanisms is essential for developing therapeutic strategies that target junction stability in disease. This article synthesizes current knowledge on the negative regulation of adherens junction organization, covering the molecular players, regulatory mechanisms, disease relevance, and experimental models used to study this process. By integrating QuickGO annotations with published literature, we provide a research-grade overview for scientists investigating cell adhesion dynamics.
negative regulation of adherens junction organization At A Glance
| GO ID | GO:1903392 |
|---|---|
| GO term | negative regulation of adherens junction organization |
| Ontology | biological_process |
| Synonym | down-regulation of adherens junction organization; inhibition of adherens junction assembly and maintenance; negative regulation of adherens junction assembly and maintenance |
| Major function | Stops, prevents, or reduces the frequency, rate, or extent of adherens junction organization |
| Related cellular component | Adherens junction (GO:0005912) |
| Related biological process | Adherens junction organization (GO:0034332) |
| Regulatory direction | Negative |
| Common experimental readouts | Cadherin localization, junctional integrity, barrier function assays |
What Is GO:1903392?
GO:1903392, negative regulation of adherens junction organization, is a biological process defined as any process that stops, prevents, or reduces the frequency, rate, or extent of adherens junction organization [QuickGO]. In other words, it encompasses all molecular events that lead to the disassembly, destabilization, or inhibition of the assembly of cadherin-based cell-cell adhesion complexes. This term is distinct from positive regulation, which would promote junction formation. The synonyms include down-regulation of adherens junction assembly and maintenance, inhibition of adherens junction organization, and negative regulation of adherens junction assembly and maintenance [QuickGO].
Why Is negative regulation of adherens junction organization Important in Cell Biology?
Negative regulation of adherens junction organization is fundamentally important because it controls tissue plasticity and barrier function. During development, transient disassembly of adherens junctions allows cells to migrate and rearrange, which is essential for morphogenesis. In adult tissues, dynamic regulation of junctions is required for wound healing and immune cell extravasation. However, when this process is dysregulated, it can lead to cancer progression by promoting invasion and metastasis, or to vascular leak in inflammatory diseases [3, 7]. Thus, understanding the mechanisms that negatively regulate adherens junctions is critical for both basic biology and therapeutic development.
• Enables epithelial-to-mesenchymal transition (EMT) during development and cancer metastasis.
• Regulates endothelial barrier function and vascular permeability [3, 4].
• Required for tissue remodeling and wound healing.
• Influenced by Rho GTPase signaling, which is frequently altered in cancer [1, 2].
• Modulated by glucocorticoids and Ras-dependent pathways [2, 4].
• Involves cytoskeletal forces that mechanically destabilize junctions.
• Impacts intercalated disc organization in cardiac tissue.
• Merlin/NF2 tumor suppressor regulates junction stability.
• Dysregulation contributes to inflammatory diseases and edema.
• Provides targets for therapeutic intervention in metastasis and vascular disorders.
What Happens During negative regulation of adherens junction organization?
Initiation by Signaling Cues
In simple terms: The process starts when external or internal signals tell the cell to break down its connections with neighboring cells.
Negative regulation of adherens junction organization is initiated by signaling pathways that respond to developmental cues, growth factors, or mechanical stress. For example, Ras-dependent signal transduction can down-regulate endothelial adherens junctions. Glucocorticoids can also trigger down-regulation of RhoA, which is required for steroid-induced reorganization of junctional complexes. These signals converge on intracellular effectors that ultimately destabilize cadherin-mediated adhesion.
Rho GTPase Activation and Cytoskeletal Remodeling
In simple terms: Small molecular switches called Rho GTPases get activated and cause the cell's internal skeleton to pull the junctions apart.
Rho GTPases, including RhoA, Rac1, and Cdc42, are central regulators of adherens junction dynamics. Activation of RhoA often promotes actomyosin contractility, which generates tension that pulls adherens junctions apart. Conversely, Rac1 and Cdc42 can have context-dependent roles in junction disassembly. The interdependence of Rho GTPases and apicobasal cell polarity further modulates junction stability. Cytoskeletal forces, such as those induced by fluid shear stress, drive adherens junction remodeling through mechanotransduction pathways.
Cadherin Endocytosis and Degradation
In simple terms: The adhesion proteins themselves are removed from the cell surface and broken down.
A key step in negative regulation is the internalization and degradation of cadherins, particularly E-cadherin. Signaling pathways that promote junction disassembly often stimulate cadherin endocytosis, reducing the amount of adhesion molecules available at the cell surface. This process is regulated by post-translational modifications and interactions with adaptor proteins. While specific mechanisms vary by cell type, the net result is a loss of junctional integrity [1, 4].
Disassembly of Junctional Complexes
In simple terms: The entire junction structure falls apart, allowing cells to separate.
Once cadherins are removed and the cytoskeleton is reorganized, the adherens junction complex disassembles. This involves the dissociation of catenins (e.g., β-catenin) from cadherins and the dispersal of junctional proteins. ZO-1, a scaffolding protein, determines adherens and gap junction localization at intercalated disks, and its regulation impacts junction stability. The disassembly process is often coordinated with changes in cell polarity and is reversible under certain conditions.
Key Genes Involved in GO:1903392 negative regulation of adherens junction organization
The following genes and proteins are key players in the negative regulation of adherens junction organization, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RHOA | Promotes actomyosin contractility and junction disassembly | Central regulator of adherens junction stability; target for cancer and vascular studies [1, 2] |
| RAC1 | Context-dependent regulation of junction dynamics | Modulates cell polarity and junction remodeling |
| CDC42 | Regulates cytoskeletal organization and junction stability | Interacts with polarity pathways to influence adherens junctions |
| CDH1 | E-cadherin; core adhesion molecule | Its down-regulation is a hallmark of EMT and metastasis |
| CTNNB1 | β-catenin; links cadherins to cytoskeleton | Dual role in adhesion and Wnt signaling; key in cancer |
| TJP1 | ZO-1; scaffolding protein at junctions | Determines adherens and gap junction localization |
| NF2 | Merlin; tumor suppressor | Regulates junction stability and growth control |
| HRAS | Ras-dependent signaling | Down-regulates endothelial adherens junctions |
| ARHGAP | Rho GTPase activating proteins | Modulate RhoA activity to affect junctions |
| ARHGEF | Rho guanine nucleotide exchange factors | Activate Rho GTPases at junctions |
| MYH9 | Non-muscle myosin heavy chain | Generates contractile forces that destabilize junctions |
| ACTN1 | Alpha-actinin; actin crosslinker | Reinforces cytoskeletal tension at junctions |
| VCL | Vinculin; focal adhesion protein | Links actin to cadherins and modulates junction strength |
| CDH5 | VE-cadherin; endothelial adhesion | Regulates vascular permeability [3, 4] |
| KRT8 | Keratin 8; intermediate filament | Contributes to mechanical stability of junctions |
| SGK1 | Serum/glucocorticoid-regulated kinase | Mediates glucocorticoid effects on junctions |
| DSP | Desmoplakin; desmosomal protein | Interacts with adherens junctions in cardiac tissue |
How Is negative regulation of adherens junction organization Regulated?
The negative regulation of adherens junction organization is itself tightly regulated by upstream signaling pathways. Rho GTPase activity is controlled by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs), which respond to extracellular signals. Glucocorticoid signaling down-regulates RhoA, which is required for steroid-induced reorganization of junctional complexes. Ras-dependent pathways can also promote junction disassembly. Mechanical forces, such as shear stress, regulate junction remodeling through cytoskeletal tension and mechanosensitive proteins. Additionally, the tumor suppressor merlin/NF2 modulates junction stability through conformational flexibility. These regulatory layers ensure that adherens junction disassembly occurs at the right time and place.
negative regulation of adherens junction organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CDH1 | Cancer metastasis (loss of E-cadherin) | CRISPR knockout in epithelial cancer cell lines; invasion assays |
| RHOA | Cancer progression, vascular permeability | Point mutation (constitutively active) knock-in; endothelial barrier assays |
| NF2 | Neurofibromatosis type 2, meningioma | Knockout in Schwann cells or meningioma cells; junction stability assays |
| TJP1 | Cardiac arrhythmia, cardiomyopathy | Knockout in cardiomyocytes; immunofluorescence for junction proteins |
| HRAS | Vascular leak, inflammation | Overexpression of activated HRAS in endothelial cells; permeability assays |
Cancer Metastasis
Loss of adherens junctions is a critical step in epithelial-to-mesenchymal transition (EMT), enabling cancer cells to detach from the primary tumor and invade surrounding tissues. Negative regulation of adherens junction organization, driven by Rho GTPase signaling and growth factor pathways, promotes this process [1, 4]. Down-regulation of E-cadherin (CDH1) is a hallmark of metastatic carcinomas, and its expression is often reduced by transcriptional repressors or protein degradation. Targeting the pathways that negatively regulate adherens junctions could therefore inhibit metastasis.
Vascular Permeability and Inflammation
In endothelial cells, adherens junctions maintain the vascular barrier. Negative regulation of these junctions leads to increased permeability, contributing to edema and inflammation [3, 4]. Pro-angiogenic factors and inflammatory cytokines can trigger junction disassembly through Ras-dependent and Rho GTPase pathways. Understanding these mechanisms is important for developing therapies for conditions such as acute respiratory distress syndrome and sepsis.
Cardiac Disease
In the heart, adherens junctions at intercalated discs are essential for mechanical coupling between cardiomyocytes. ZO-1 determines the localization of adherens and gap junctions at these sites, and its dysregulation can lead to arrhythmias and cardiomyopathy. Negative regulation of adherens junction organization may contribute to pathological remodeling after myocardial infarction.
Developmental Disorders
Proper regulation of adherens junction disassembly is required for normal development. Mutations in genes that control junction stability, such as NF2, can cause developmental defects and tumor predisposition. Merlin/NF2 functions as a tumor suppressor by stabilizing adherens junctions, and its loss leads to uncontrolled cell proliferation.
From negative regulation of adherens junction organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene increase adherens junction stability? | CRISPR knockout in epithelial cells followed by junction integrity assays |
| Does a specific point mutation in RhoA affect junction disassembly? | Point mutation knock-in (e.g., constitutively active RhoA) in endothelial cells |
| Can a candidate gene's localization at junctions be tracked? | Knock-in of fluorescent tag (e.g., GFP) at the endogenous locus |
| Does overexpression of a negative regulator disrupt junctions? | Overexpression of the gene of interest in cell lines, followed by imaging |
| Which genes are essential for junction disassembly in a genome-wide screen? | CRISPR library screening with a junction integrity readout |
| What are the transcriptomic changes during junction disassembly? | RNA-seq after inducing negative regulation in a controlled model |
How to Study the negative regulation of adherens junction organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Immunofluorescence | Localization and intensity of junction proteins | Visualizing adherens junction disassembly |
| TEER | Barrier function of cell monolayers | Quantifying permeability changes |
| Co-immunoprecipitation | Protein-protein interactions | Assessing cadherin-catenin association |
| Live-cell imaging | Dynamic changes in junction morphology | Tracking disassembly over time |
| CRISPR library screening | Genes affecting junction integrity | Identifying negative regulators |
| RNA-seq | Transcriptional changes | Profiling gene expression during disassembly |
| Western blot | Protein expression and modifications | Validating knockdown or overexpression |
Imaging of Junctional Proteins
Immunofluorescence and live-cell imaging are standard methods to visualize adherens junction organization and disassembly. Antibodies against E-cadherin, β-catenin, and ZO-1 allow researchers to track junction morphology and protein localization. Fluorescently tagged proteins can be used to monitor dynamics in real time.
Barrier Function Assays
For endothelial and epithelial cells, barrier function can be measured using trans-epithelial/endothelial electrical resistance (TEER) or permeability assays with fluorescent tracers. These methods quantify the functional consequence of negative regulation of adherens junctions [3, 4].
Biochemical Analysis of Junction Complexes
Co-immunoprecipitation and Western blotting can assess the association between cadherins and catenins, as well as post-translational modifications that regulate junction stability. This helps identify molecular changes during disassembly [1, 2].
Genome-wide Screening
CRISPR-based library screening enables unbiased identification of genes that negatively regulate adherens junction organization. Cells are transduced with a sgRNA library, and junction integrity is assessed by imaging or flow cytometry, followed by sequencing to identify enriched sgRNAs.
How CRISPR Can Be Used to Study GO:1903392 negative regulation of adherens junction organization
Knockout
CRISPR knockout is used to delete genes suspected of negatively regulating adherens junction organization. For example, knocking out RHOA or its regulators can test whether they are required for junction disassembly. Knockout cell lines are validated by sequencing and Western blotting, then subjected to junction integrity assays.
Point Mutation
Point mutations can be introduced to mimic activating or inactivating modifications in key regulators. For instance, a constitutively active RhoA mutant can be knocked into the endogenous locus to study its effect on junction stability without confounding overexpression artifacts.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags allows real-time tracking of junction proteins at endogenous expression levels. This is particularly useful for studying dynamic changes in protein localization during disassembly.
Overexpression
Overexpression of candidate negative regulators can be achieved by CRISPR-mediated insertion of a strong promoter or by lentiviral delivery. This approach is used to test sufficiency of a gene to disrupt adherens junctions.
How EDITGENE Supports negative regulation of adherens junction organization Research
Researchers studying negative regulation of adherens junction organization-related genes often need to determine whether a candidate gene is causally involved in junction disassembly or is merely correlated with it. This requires precise genetic manipulation, which is where EDITGENE's CRISPR services can accelerate discovery.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of adherens junction organization research.
Frequently Asked Questions About negative regulation of adherens junction organization
What is GO:1903392?
GO:1903392 is the Gene Ontology term for negative regulation of adherens junction organization, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of adherens junction organization [QuickGO].
What genes are involved in negative regulation of adherens junction organization?
Key genes include RHOA, RAC1, CDC42, CDH1, CTNNB1, TJP1, NF2, and HRAS, among others [1, 2, 4, 6, 7].
How does RhoA regulate adherens junctions?
RhoA promotes actomyosin contractility, which generates tension that can pull adherens junctions apart, leading to disassembly.
What is the role of E-cadherin in adherens junction disassembly?
E-cadherin is the core adhesion molecule; its endocytosis and degradation are key steps in junction disassembly.
Which diseases are associated with negative regulation of adherens junctions?
Cancer metastasis, vascular permeability, cardiac arrhythmias, and developmental disorders are associated with dysregulated junction disassembly [1, 3, 6, 7].
How can I study negative regulation of adherens junction organization?
Common methods include immunofluorescence, TEER, co-immunoprecipitation, live-cell imaging, and CRISPR screening [1, 3, 6].
What is the difference between adherens junction organization and its negative regulation?
Adherens junction organization (GO:0034332) is the process of assembling junctions, while negative regulation (GO:1903392) inhibits or reverses that assembly [QuickGO].
Can CRISPR be used to study adherens junction disassembly?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to test gene function in junction disassembly [1, 4].
What signaling pathways negatively regulate adherens junctions?
Ras-dependent signaling, glucocorticoid pathways, and Rho GTPase signaling are major pathways that negatively regulate adherens junctions [1, 2, 4].
What are the synonyms for GO:1903392?
Synonyms include down-regulation of adherens junction organization, inhibition of adherens junction assembly and maintenance, and negative regulation of adherens junction assembly and maintenance [QuickGO].
Conclusion
Negative regulation of adherens junction organization (GO:1903392) is a critical biological process that controls cell-cell adhesion dynamics. It is essential for development, tissue remodeling, and immune responses, but its dysregulation contributes to cancer, vascular disease, and cardiac disorders. Key regulators include Rho GTPases, cadherins, and scaffolding proteins, which are modulated by signaling pathways and mechanical forces. Understanding these mechanisms offers opportunities for therapeutic intervention. EDITGENE provides comprehensive CRISPR solutions to study this process, from knockout and point mutation models to library screening and bioinformatics.
References
- 1. Mack NA et al.. 2014. The interdependence of the Rho GTPases and apicobasal cell polarity.. Small GTPases 5(2):10 PMID: 25469537
- 2. Rubenstein NM et al.. 2003. Glucocorticoid down-regulation of RhoA is required for the steroid-induced organization of the junctional complex and tight junction formation in rat mammary epithelial tumor cells.. J Biol Chem 278(12):10353-60 PMID: 12525486
- 3. Surendran V et al.. 2024. Magnetically Integrated Tumor-Vascular Interface System to Mimic Pro-angiogenic Endothelial Dysregulations for On-Chip Drug Testing.. ACS Appl Mater Interfaces 16(36):47075-47088 PMID: 39196896
- 4. Hegland DD et al.. 1999. Regulation of endothelial cell adherens junctions by a Ras-dependent signal transduction pathway.. Biochem Biophys Res Commun 260(2):371-6 PMID: 10403777
- 5. Verma D et al.. 2017. Flow induced adherens junction remodeling driven by cytoskeletal forces.. Exp Cell Res 359(2):327-336 PMID: 28803065
- 6. Palatinus JA et al.. 2011. ZO-1 determines adherens and gap junction localization at intercalated disks.. Am J Physiol Heart Circ Physiol 300(2):H583-94 PMID: 21131473
- 7. Primi MC et al.. 2021. Conformational flexibility determines the Nf2/merlin tumor suppressor functions.. Matrix Biol Plus 12:100074 PMID: 34337379
